4.7 Review

Effects of nanomaterial physicochemical properties on in vivo toxicity

Journal

ADVANCED DRUG DELIVERY REVIEWS
Volume 61, Issue 6, Pages 457-466

Publisher

ELSEVIER
DOI: 10.1016/j.addr.2009.03.010

Keywords

Nanomaterial; Toxicity; In vivo; Dendrimer; Carbon nanotube; Quantum dot; Gold nanoparticle; Analysis

Funding

  1. NCI NIH HHS [R21 CA132033, R21 CA132033-01] Funding Source: Medline
  2. NCRR NIH HHS [P20 RR015563-086738, P20 RR016443, P20 RR015563, P20 RR015563-096215] Funding Source: Medline
  3. NIAMS NIH HHS [R03 AR054035] Funding Source: Medline

Ask authors/readers for more resources

It is well recognized that physical and chemical properties of materials can alter dramatically at nanoscopic scale, and the growing use of nanotechnologies requires careful assessment of unexpected toxicities and biological interactions. However, most in vivo toxicity concerns focus primarily on pulmonary, oral, and dermal exposures to ultrafine particles. As nanomaterials expand as therapeutics and as diagnostic tools, parenteral administration of engineered nanomaterials should also be recognized as a critical aspect for toxicity consideration. Due to the complex nature of nanomaterials, conflicting studies have led to different views of their safety. Here, the physicochemical properties of four representative nanomaterials (dendrimers, carbon nanotubes, quantum dots, and gold nanoparticles) as it relates to their toxicity after systemic exposure is discussed. (C) 2009 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available